The objective of this study was to analyze the outcomes of patients with comorbid ischemic stroke and COVID-19.

The data for this study was obtained from 312 hospitals in 46 states in the US through the Vizient Clinical Data Base®.

For primary analysis, 166,586 patients with only ischemic stroke were used as controls and 2,086 patients with both ischemic stroke and COVID-19.

For secondary analysis, the same 2,086 patients with both ischemic stroke and COVID-19 were matched with 2,086 patients with both ischemic stroke and pneumonia.

It was found that patients with both ischemic stroke and COVID-19 had significantly increased mortality rates and were more likely to be male, younger, and Black or Hispanic.

It was also found that among the matched cohort of patients, those with both COVID-19 and ischemic stroke were at a higher risk of death and had lower rates of favorable discharge from the hospital.